nicotinamide mononucleotide has been researched along with Dermatitis, Atopic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Ding, H; Gao, JF; Luo, F; Meng, ZD; Tang, L; Zhang, YY | 1 |
1 other study(ies) available for nicotinamide mononucleotide and Dermatitis, Atopic
| Article | Year |
|---|---|
Nicotinamide mononucleotide ameliorates DNFB-induced atopic dermatitis-like symptoms in mice by blocking activation of ROS-mediated JAK2/STAT5 signaling pathway.
Topics: Animals; Cytokines; Dermatitis, Atopic; Dinitrofluorobenzene; Mice; Nicotinamide Mononucleotide; Pruritus; Reactive Oxygen Species; Signal Transduction; Skin; STAT5 Transcription Factor; Tumor Necrosis Factor-alpha | 2022 |